8-K 1 form_8-k.htm PHMD STOCKHOLDER PROXY VOTING RESULTS ANN. MTG form_8-k.htm
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549

_____________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report (Date of earliest event reported):  August 1, 2013

        PhotoMedex, Inc.
(Exact Name of Registrant Specified in Charter)
 
 
Nevada
  
0-11635
  
59-2058100
  
 
(State or other jurisdiction
  
(Commission File Number)
  
(I.R.S. Employer
  
 
of incorporation)
      
Identification Number)
  

 
              147 Keystone Drive, Montgomeryville, Pennsylvania
   18936
  
 
              (Address of Principal Executive Offices)
(Zip Code)
  

Registrant’s telephone number, including area code:   215-619-3600
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o
  
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o
  
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o
  
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17       CFR 240.14d-2(b))

o
  
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 
 

ITEM 5.07
SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS


On August 1, 2013, PhotoMedex, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”).  The matters voted upon were:

(1) the election of eight director nominees to the Company’s board of directors to serve until the next annual meeting of the Company’s stockholders or until their successors are elected and qualify, subject to their prior death, resignation or removal; and

(2) the ratification of the appointment of Fahn Kanne & Co. Grant Thornton Israel (“Grant Thornton Israel”) to serve as the Company’s independent registered public accounting firm for the year to be ended December 31, 2013, and the ratification of the authority of the audit committee to set the compensation of Grant Thornton Israel.

The results of the voting for each proposal were as follows:

(1) Each of the director nominees to the Company’s board of directors was elected:

Nominees
Votes For
Votes Withheld       
 
Lewis C. Pell
 
11,199,466
 
137,550
Dr. Yoav Ben-Dror
10,009,634
1,327,382
Dr. Dolev Rafaeli
10,458,765
878,251
Dennis M. McGrath
10,116,537
1,220,479
Dr. Nahum Melumad
11,252,372
84,644
James W. Sight
11,310,468
26,548
Stephen P. Connelly
11,173,474
163,542
Katsumi Oneda
11,278,303
58,713

There were 1,930,401 broker non-votes for this proposal.

(2) The proposal to ratify the appointment of Fahn Kanne & Co. Grant Thornton Israel (“Grant Thornton Israel”) to serve as the Company’s independent registered public accounting firm for the year to be ended December 31, 2013, and to ratify the authority of the audit committee to set the compensation of Grant Thornton Israel, was approved:

Votes For
Votes Against
Abstain
 
12,993,676
 
270,690
 
3,051



 
 
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
PHOTOMEDEX, INC.
 
 
Date:  August 2, 2013
By:           /s/ Dennis M. McGrath                                           
 
Dennis M. McGrath
President & Chief Financial Officer